Markets closed lower Monday on poor manufacturing data from the U.S. and China while biotech stocks continued their dive - suffering their worst two-day fall since 2011. Questions have been raised over the prices some biotechs charge for drugs while concerns are rising around valuations in the sector. Fund mangers are also concerned at the prospect of recession in Russia after sanctions imposed for its incursion into Ukraine's Crimea. Jane Searle speaks with Jason Weisberg at the NYSE.

More from Video

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Video: This Startup Connects Buyers and Sellers of Legal Marijuana

Video: This Startup Connects Buyers and Sellers of Legal Marijuana

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: If You're Concerned About Visa's Run, Check Out Global Payments

Jim Cramer: If You're Concerned About Visa's Run, Check Out Global Payments

60 Seconds: What the Heck is GDPR?

60 Seconds: What the Heck is GDPR?